You may have seen the recent update from NICE with draft guidance decision not to approve Elahere for use in England. Let us know your thoughts and experiences to submit to NICE as part of the decision confirmation process.
Sign up to our newsletter
Subscribe to our newsletter to keep up to date with all the latest stories, research news and ways you can get involved with Ovarian Cancer Action.